ISSN: 1387-2877

Journal Home

Journal Guideline

Journal of Alzheimer's Disease Q1 Unclaimed

IOS Press BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Alzheimer's Disease is a journal indexed in SJR in Medicine (miscellaneous) and Neuroscience (miscellaneous) with an H index of 163. It has an SJR impact factor of 1,146 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,146.

Journal of Alzheimer's Disease focuses its scope in these topics and keywords: alzheimer’s, disease, dementia, cognitive, impairment, mild, amyloid?, risk, patients, frontotemporal, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Clinical Psychology (Q1) Geriatrics and Gerontology (Q1) Medicine (miscellaneous) (Q1) Psychiatry and Mental Health (Q1) Neuroscience (miscellaneous) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,146

SJR Impact factor

163

H Index

826

Total Docs (Last Year)

2346

Total Docs (3 years)

45843

Total Refs

9798

Total Cites (3 years)

2332

Citable Docs (3 years)

3.81

Cites/Doc (2 years)

55.5

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Public Health Q1
Annual Review of Pathology: Mechanisms of Disease Q1
The Lancet Global Health Q1
Annual Review of Clinical Psychology Q1
JAMA - Journal of the American Medical Association Q1

Compare this journals

Aims and Scope

Best articles by citations

Visit-to-Visit Blood Pressure Variability and Alzheimer's Disease: Links and Risks

Genome-Wide Association Study Identifies SLAMF1 Affecting the Rate of Memory Decline

Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease

Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study

Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia

Amyloid-beta/Drug Interactions from Computer Simulations and Cell-Based Assays

Age-Dependent Increment of Hydroxymethylation in the Brain Cortex in the Triple-Transgenic Mouse Model of Alzheimer's Disease

The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L)

Altered Neurotransmission Prior to Cognitive Decline in AbetaPP/PS1 Mice, a Model of Alzheimer's Disease

Serum MHPG Strongly Predicts Conversion to Alzheimer's Disease in Behaviorally Characterized Subjects with Down Syndrome

Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study

SHOW MORE ARTICLES

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Incorporating biomarkers into clinical drug trials in Alzheimer's disease

Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease

Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model

Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease

Albumin-Blunted Deleterious Effect of Amyloid-beta by Preventing the Internalization of the Peptide into Neurons

Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-beta Peptides: Protective Effect of Human Serum Albumin

Association between a-Klotho and Deep White Matter Lesions in the Brain: A Pilot Case Control Study Using Brain MRI

Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease

Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models